(06.04.2020)

The Japanese drug camostat mesylate has now arrived in Denmark and the first patient at Aarhus University Hospital is now testing the effect of the drug against COVID-19.

Just one week ago, researchers at Aarhus University Hospital and Aarhus University received DKK 5 million from the Lundbeck Foundation to test if a new Japanese drug against heartburn – camostat mesylate – is useful to treat the new coronavirus (COVID-19).